0.4257
Precedente Chiudi:
$0.3961
Aprire:
$0.4093
Volume 24 ore:
2.65M
Relative Volume:
0.28
Capitalizzazione di mercato:
$21.40M
Reddito:
-
Utile/perdita netta:
$-11.53M
Rapporto P/E:
-0.0883
EPS:
-4.82
Flusso di cassa netto:
$-11.12M
1 W Prestazione:
-11.84%
1M Prestazione:
+110.68%
6M Prestazione:
+56.31%
1 anno Prestazione:
-65.95%
Processa Pharmaceuticals Inc Stock (PCSA) Company Profile
Nome
Processa Pharmaceuticals Inc
Settore
Industria
Telefono
443-776-3133
Indirizzo
601 21ST STREET, SUITE 300, VERO BEACH
Confronta PCSA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
PCSA
Processa Pharmaceuticals Inc
|
0.4251 | 22.11M | 0 | -11.53M | -11.12M | -4.82 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
412.39 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
476.55 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
579.32 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
811.36 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
316.54 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-04-25 | Iniziato | H.C. Wainwright | Buy |
Processa Pharmaceuticals Inc Borsa (PCSA) Ultime notizie
Can you recover from losses in Processa Pharmaceuticals Inc.July 2025 Intraday Action & Community Trade Idea Sharing - newser.com
Should you wait for a breakout in Processa Pharmaceuticals Inc.Trade Volume Summary & Safe Entry Zone Tips - newser.com
Top chart patterns to watch in Processa Pharmaceuticals Inc.July 2025 Gainers & Consistent Income Trade Ideas - newser.com
Is Processa Pharmaceuticals Inc. stock a buy before product launchesEarnings Recap Summary & AI Driven Stock Price Forecasts - newser.com
Published on: 2025-10-14 02:28:39 - newser.com
Published on: 2025-10-14 00:40:32 - newser.com
What data driven models say about Processa Pharmaceuticals Inc.’s future2025 Earnings Impact & Capital Protection Trading Alerts - newser.com
What moving averages say about Processa Pharmaceuticals Inc.2025 Market Outlook & Verified Swing Trading Watchlist - newser.com
Applying big data sentiment scoring on Processa Pharmaceuticals Inc.Weekly Gains Summary & Scalable Portfolio Growth Methods - newser.com
Is Processa Pharmaceuticals Inc. still worth holding after the dipJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - newser.com
Using economic indicators to assess Processa Pharmaceuticals Inc. potentialPortfolio Gains Summary & Technical Pattern Alert System - newser.com
Using AI based signals to follow Processa Pharmaceuticals Inc.Market Weekly Review & Momentum Based Trading Ideas - newser.com
Can swing trading help recover from Processa Pharmaceuticals Inc. lossesJuly 2025 Volume & Free Technical Confirmation Trade Alerts - newser.com
Live market analysis of Processa Pharmaceuticals Inc.Trade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Forecasting Processa Pharmaceuticals Inc. price range with options dataWeekly Profit Analysis & Weekly High Momentum Picks - newser.com
Is Processa Pharmaceuticals Inc. stock a defensive play in 2025July 2025 Spike Watch & Capital Protection Trading Alerts - newser.com
How Processa Pharmaceuticals Inc. stock reacts to inflationary pressures2025 Momentum Check & Free Expert Verified Stock Movement Alerts - newser.com
Why Processa Pharmaceuticals Stock Rose Almost 38% Overnight? - Benzinga
Biotech Stocks Surge After Hours: PCSA, PALI, And QTTB Lead On Volume And Speculation - Nasdaq
TELO, PCSA, RVPH, NMTC, BRTX Jump In After-Hours Trading On Light News Flow And Select Updates - RTTNews
Momentum divergence signals in Processa Pharmaceuticals Inc. chart2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com
Published on: 2025-10-05 04:03:55 - newser.com
Can machine learning forecast Processa Pharmaceuticals Inc. recovery2025 Market Sentiment & Free Reliable Trade Execution Plans - newser.com
Published on: 2025-10-03 04:24:10 - newser.com
Published on: 2025-10-03 02:09:35 - newser.com
Processa Pharmaceuticals' chief business officer buys $34,691 in stock - MSN
Ulcerated Necrobiosis Lipoidica Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Processa Pharmaceuticals - The Globe and Mail
Strategies to average down on Processa Pharmaceuticals Inc.Quarterly Trade Review & Daily Growth Stock Investment Tips - newser.com
Processa Pharmaceuticals Inc Azioni (PCSA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Processa Pharmaceuticals Inc Azioni (PCSA) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Ng George K | Chief Executive Officer |
Jan 27 '25 |
Buy |
0.80 |
87,200 |
69,542 |
87,200 |
Young David | Pres. Research & Development |
Jan 27 '25 |
Buy |
0.80 |
124,500 |
99,289 |
205,405 |
Lin Patrick | Chief Business - Strategy Off |
Jan 27 '25 |
Buy |
0.80 |
43,500 |
34,691 |
43,500 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):